Collective Audience (CAUD) Competitors $0.03 +0.03 (+30,900.00%) As of 08/22/2025 01:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock CAUD vs. LICN, WAI, DKDCA, RVYL, SRAX, TC, VCIG, APDN, AUUD, and HAOShould you be buying Collective Audience stock or one of its competitors? The main competitors of Collective Audience include Lichen International (LICN), Top KingWin (WAI), Data Knights Acquisition (DKDCA), Ryvyl (RVYL), SRAX (SRAX), Token Cat (TC), VCI Global (VCIG), Applied DNA Sciences (APDN), Auddia (AUUD), and Haoxi Health Technology (HAO). These companies are all part of the "business services" industry. Collective Audience vs. Its Competitors Lichen International Top KingWin Data Knights Acquisition Ryvyl SRAX Token Cat VCI Global Applied DNA Sciences Auddia Haoxi Health Technology Lichen International (NASDAQ:LICN) and Collective Audience (NASDAQ:CAUD) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment. Do institutionals and insiders have more ownership in LICN or CAUD? 60.8% of Collective Audience shares are held by institutional investors. 58.0% of Collective Audience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer LICN or CAUD? In the previous week, Lichen International had 1 more articles in the media than Collective Audience. MarketBeat recorded 1 mentions for Lichen International and 0 mentions for Collective Audience. Lichen International's average media sentiment score of 0.00 equaled Collective Audience'saverage media sentiment score. Company Overall Sentiment Lichen International Neutral Collective Audience Neutral Which has higher valuation & earnings, LICN or CAUD? Collective Audience has lower revenue, but higher earnings than Lichen International. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLichen International$41.48M0.06-$6.14MN/AN/ACollective Audience$12.14M0.06-$4.57MN/AN/A Is LICN or CAUD more profitable? Company Net Margins Return on Equity Return on Assets Lichen InternationalN/A N/A N/A Collective Audience N/A N/A N/A Which has more risk and volatility, LICN or CAUD? Lichen International has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Collective Audience has a beta of 4.2, meaning that its stock price is 320% more volatile than the S&P 500. SummaryCollective Audience beats Lichen International on 4 of the 7 factors compared between the two stocks. Get Collective Audience News Delivered to You Automatically Sign up to receive the latest news and ratings for CAUD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CAUD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAUD vs. The Competition Export to ExcelMetricCollective AudienceManagement consulting services IndustryComputer SectorNASDAQ ExchangeMarket Cap$737K$18.39M$29.26B$9.58BDividend YieldN/AN/A3.09%4.10%P/E RatioN/A6.6354.4226.04Price / Sales0.0667.671,259.97102.77Price / CashN/A25.4035.2058.48Price / BookN/A0.549.586.61Net Income-$4.57M-$13.46M$805.43M$265.56M7 Day PerformanceN/A0.02%1.55%1.97%1 Month PerformanceN/A-3.17%-0.64%-0.36%1 Year PerformanceN/A-18.40%24,052.26%19.03% Collective Audience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAUDCollective AudienceN/A$0.03+30,900.0%N/A-93.3%$737K$12.14M0.0023Gap UpLICNLichen InternationalN/A$4.65-3.1%N/A-98.9%$2.75M$41.48M0.00390News CoveragePositive NewsGap DownWAITop KingWinN/A$0.35-3.0%N/AN/A$2.55M$3.75M0.00N/ANews CoveragePositive NewsGap DownDKDCAData Knights AcquisitionN/A$0.47+3.5%N/A-26.3%$2.42MN/A-2.462RVYLRyvyl1.5394 of 5 stars$0.28-7.0%N/A-65.4%$2.37M$56M-0.0350Gap DownSRAXSRAXN/A$0.08flatN/A-88.9%$2.22M$29.29M0.00130TCToken CatN/A$0.61+1.0%N/A-68.1%$1.92M$6.74M0.00620Positive NewsUpcoming EarningsVCIGVCI Global0.6258 of 5 stars$0.86+1.0%N/A-99.6%$1.80M$27.83M0.00102APDNApplied DNA Sciences0.0736 of 5 stars$4.02-1.2%N/A-99.7%$1.77M$3.43M-0.0170Short Interest ↑AUUDAuddia0.9916 of 5 stars$2.50+1.6%N/A-86.7%$1.65MN/A-0.0820Short Interest ↓HAOHaoxi Health TechnologyN/A$1.24+7.0%N/A-98.7%$1.60M$48.52M0.0029Gap Up Related Companies and Tools Related Companies Lichen International Competitors Top KingWin Competitors Data Knights Acquisition Competitors Ryvyl Competitors SRAX Competitors Token Cat Competitors VCI Global Competitors Applied DNA Sciences Competitors Auddia Competitors Haoxi Health Technology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CAUD) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collective Audience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collective Audience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access